A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcription Factor (MYC) Protein Expression in Diffuse Large B-Cell Lymphoma

Summary

This is a single center imaging study investigating the use of PET with 68Ga-citrate in patients with DLBCL or BCLU.

Timeline

Start

2016-06-13

Primary completion

2018-04-09

Completion

2018-04-09

Outcome

Outcome not reported

Stopped: “Unexpected dose production issues prevented study start up”

Drugs

Indications